日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Response to the Union's statement on ongoing conflicts and impact on health services

对工会关于持续冲突及其对医疗服务影响的声明的回应

Ahmad Khan, F; Menzies, R; Ashesh, A; Bijker, E; Brode, S; Carter, E J; Casas, E C; Campbell, J; Denkinger, C; Deborggraeve, S; Evlampidou, I; Furin, J; Farhat, M; Farouk, M M O; Gafar, F; Günther, G; Guglielmetti, L; Isaakidis, P; Jouberton, F; Khambati, N; Khan, P Y; Khan, U; Long, R; Law, S; Matteelli, A; Malden, D; Motta, I; Murray, M; Masini, T; Rich, M; Ruslami, R; Sepulcri, C; Sunyoto, T; Tunesi, S; Wong, E B; Zaffagnini, A

Infectivity duration of HCoV-OC43, a surrogate for SARS-CoV-2, in artificial bodily fluids on stainless steel simulating common nonporous surfaces

HCoV-OC43(SARS-CoV-2 的替代病毒)在模拟常见无孔表面的不锈钢人工体液中的感染持续时间

Furin, William; Tran-Basha, Lisa; Yancey, Olivia; Edwards, Jonathan; Edwards, Martinique; Whitworth, Carrie; Park, Geun Woo

Fomite workshop recommendations addressing the role of surfaces in virus transmission in the built environment

针对建筑环境中物体表面在病毒传播中所起的作用,开展了关于污染物传播研讨会的建议。

Abney, Sarah E; Bloomfield, Sally F; Boone, Stephanie A; Cutts, Todd; Gerba, Charles P; Ijaz, M Khalid; Lyons, Amanda K; Maillard, Jean-Yves; Mena, Kristina D; McKinney, Julie; Park, Geun Woo; Scott, Elizabeth; Reynolds, Kelly A; Rutala, William A; Sattar, Syed A; Weber, David J; Verhougstraete, Marc P; Williams, Margaret M; Furin, William A; Wilson, Amanda M; Whitworth, J Carrie; Zargar, Bahram

End of treatment and 12-month post-treatment outcomes in patients treated with all-oral regimens for rifampicin-resistant tuberculosis in Ukraine: a prospective cohort study

乌克兰接受全口服方案治疗的利福平耐药结核病患者的治疗结束及治疗后12个月结局:一项前瞻性队列研究

Fardhdiani, Vini; Trush, Olena; Lytvynenko, Nataliia; Pylypchuk, Svitlana; Terleeva, Yana; Malakyan, Khachatur; Rupasinghe, Praharshinie; Wally, Yves; Duka, Marve; Didyk, Vitaly Stephanovich; Siomak, Olga Valentinovna; Blyzniuk, Oleksandr; Furin, Jennifer; Donchuk, Dmytro; Laxmeshwar, Chinmay; Isaakidis, Petros

Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in research

携手抗击结核病:呼吁让受结核病影响的社区成为研究的重要合作伙伴

Venkatesan, N; Faust, L; Lobo, R; Enkh-Amgalan, H; Kunor, T; Sifumba, Z; Rane, S; O'Brien, K; Kumar, B; Maimbolwa, C N; Mayta, M; Patel, H; Huong, L M; Heitkamp, P; Huddart, S; Romanowski, K; Hiebert, M; Zimmer, A J; MacLean, E L; Caceres-Cardenas, G; Villa Castillo, L; Black, J; Batchu, M; Tschampl, C A; Rea, E; Campbell, T; Heffernan, C; Long, R; Raithby, L; Daftary, A; Chorna, Y; Zheng, A; Martinez, L; Kulkarni, S; Denkinger, C M; Castro, M D M; Sulis, G; Furin, J; McKenna, L; Frick, M; Nathavitharana, R R; Oga-Omenka, C; Ananthakrishnan, R; Malar, J; Ugarte-Gil, C; Vandevelde, W; Kerkhoff, A D; Winarni, P; Fox, G; Nguyen, T A; Teo, A K J; Yapa, H M; Pham, N Y; Ratnasingham, A; Bernays, S; Trinh, H D; Khan, U; Alvarez, G G; Deluca, A; Nash, M; Rucsineanu, O; Vasiliu, A; Stillo, J; Nahid, P; Pai, M; Johnston, J; Harries, A D; Golub, J E

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

ACTG A5409 (RAD-TB):一项针对肺结核治疗新方案的 II 期随机、适应性、剂量范围、开放标签试验的研究方案

Harrison, Linda J; Velásquez, Gustavo E; Kempker, Russell R; Imperial, Marjorie Z; Nuermberger, Eric; Dorman, Susan E; Ignatius, Elisa; Granche, Janeway; Phillips, Patrick P J; Furin, Jennifer; Yang, Eunsol; Foley, Colleen; Chiambah, Shawn; Rogers, Rochelle; Van Grack, Austin; Roa, Jhoanna; Shenje, Justin; Nerette, Sandy; Kanyama, Cecilia; Kyeyune, Rachel Bakyayita; Mendoza-Ticona, Alberto; Murtaugh, William; Foraida, Salah; Goth, Melanie; Vernon, Andrew; Dooley, Kelly E; Savic, Radojka M

"Six months is a lot of time to lie": Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trial

“六个月的时间足够撒谎了”:结核病治疗试验参与者对污名化的预期、披露意愿和治疗偏好

Mugodhi, Faith; Kanyama, Cecilia; Makiya, Francis; Metcalfe, John; Potani, Charity; Scarsi, Kimberly K; Weir, Isabelle; Furin, Jennifer

ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

ACTG A5409 (RAD-TB):一项针对肺结核治疗新方案的 II 期随机、适应性、剂量范围、开放标签试验的研究方案

Harrison, Linda; Velasquez, Gustavo E; Kempker, Russell R; Imperial, Marjorie Z; Nuermberger, Eric; Dorman, Susan E; Ignatius, Elisa; Granche, Janeway; Phillips, Patrick Pj; Furin, Jennifer; Yang, Eunsol; Foley, Colleen; Chiambah, Shawn; Rogers, Rochelle; Van Grack, Austin; Roa, Jhoanna; Shenje, Justin; Nerette, Sandy; Kanyama, Cecilia; Kyeyune, Rachel Bakyayita; Mendoza-Ticona, Alberto; Murtaugh, William; Foraida, Salah; Goth, Melanie; Vernon, Andrew; Dooley, Kelly E; Savic, Radojka M

Reimagining community engagement in TB elimination: a perspective from the field

重新构想结核病消除中的社区参与:来自一线的视角

Ashesh, A; Mehra, C; Madan, V; Furin, J

The time is now: making the case for compassionate use/pre-approval access to new TB drugs

现在正是时候:争取对新型结核病药物进行同情用药/预先批准使用。

Reuter, A; Stillo, J; Thi, S S; Motta, I; Migliori, G B; Mesic, A; Mbenga, M; Howell, P; Guglielmetti, L; Gebhard, A; DeCroo, T; D'Ambrosio, L; Furin, J